Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis
Authors:
- Takeshi FutataniTFTakeshi Futatani
- Yue WangYWYue Wang
- Keiko NomuraKNKeiko Nomura
- Kentaro ShinozakiKSKentaro Shinozaki
- Hiroyoshi MatsukuraHMHiroyoshi Matsukura
- Takeo KubotaTKTakeo Kubota
- Satoshi TsukadaSTSatoshi Tsukada
- Toshio MiyawakiTMToshio Miyawaki
- 1 December 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (6) , 1012-1020
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Signaling network of the Btk family kinasesOncogene, 2000
- Atypical X-linked Agammaglobulinemia Diagnosed in Three Adults.Internal Medicine, 1999
- Mutations in Btk in Patients with Presumed X-Linked AgammaglobulinemiaThe American Journal of Human Genetics, 1998
- Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLAClinical and Experimental Immunology, 1998
- X-Linked Agammaglobulinemia A Clinical and Molecular AnalysisMedicine, 1996
- Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinaseHuman Molecular Genetics, 1994
- Role of Bruton's tyrosine kinase in immunodeficiencyCurrent Opinion in Immunology, 1994
- Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID MiceScience, 1993
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993
- Clonal diversity in the B cell repertoire of patients with X-linked agammaglobulinemia.Journal of Experimental Medicine, 1989